174 related articles for article (PubMed ID: 15497673)
1. Effect of the formulation on the bioequivalence of sultamicillin: tablets and suspension.
Koytchev R; Ozalp Y; Erenmemisoglu A; Kunter U; Alpan RS
Arzneimittelforschung; 2004 Sep; 54(9A):634-9. PubMed ID: 15497673
[TBL] [Abstract][Full Text] [Related]
2. Assessment of the bioequivalence of different formulations containing azithromycin (tablets and suspension).
Koytchev R; Ozalp Y; Erenmemisoglu A; van der Meer MJ; Alpan RS
Arzneimittelforschung; 2004 Sep; 54(9A):578-82. PubMed ID: 15497663
[TBL] [Abstract][Full Text] [Related]
3. Combination of losartan and hydrochlorothiazide: in vivo bioequivalence.
Koytchev R; Ozalp Y; Erenmemisoglu A; van der Meer MJ; Alpan RS
Arzneimittelforschung; 2004 Sep; 54(9A):611-7. PubMed ID: 15497669
[TBL] [Abstract][Full Text] [Related]
4. Bioequivalence study of sultamicillin suspensions.
Sailer R; Arnold P; Erenmemişoğlu A; Martin W; Tamur U; Kanzik I; Hincal AA
Arzneimittelforschung; 2007; 57(4):232-7. PubMed ID: 17515294
[TBL] [Abstract][Full Text] [Related]
5. Studies on the bioequivalence of second generation cephalosporins: cefaclor capsules and suspension.
Koytchev R; Ozalp Y; Erenmemisoglu A; Tyutyulkova N; Gatchev E; Alpan RS
Arzneimittelforschung; 2004 Sep; 54(9A):583-7. PubMed ID: 15497664
[TBL] [Abstract][Full Text] [Related]
6. Effect of the combination of lisinopril and hydrochlorothiazide on the bioequivalence of tablet formulations.
Koytchev R; Ozalp Y; Erenmemisoglu A; van der Meer MJ; Alpan RS
Arzneimittelforschung; 2004 Sep; 54(9A):605-10. PubMed ID: 15497668
[TBL] [Abstract][Full Text] [Related]
7. Studies on the bioequivalence of different strengths of tablets containing clarithromycin.
Koytchev R; Ozalp Y; Erenmemisoglu A; van der Meer MJ; Alpan RS
Arzneimittelforschung; 2004 Sep; 54(9A):588-93. PubMed ID: 15497665
[TBL] [Abstract][Full Text] [Related]
8. Clarithromycin suspension: bioequivalence studies on two different strengths.
Koytchev R; Ozalp Y; Erenmemisoglu A; van der Meer MJ; Alpan RS
Arzneimittelforschung; 2004 Sep; 54(9A):594-9. PubMed ID: 15497666
[TBL] [Abstract][Full Text] [Related]
9. Bioequivalence study of rofecoxib tablets.
Koytchev R; Ozalp Y; Erenmemisoglu A; van der Meer MJ; Alpan RS
Arzneimittelforschung; 2004 Sep; 54(9A):624-8. PubMed ID: 15497671
[TBL] [Abstract][Full Text] [Related]
10. Bioequivalence study of atorvastatin tablets.
Koytchev R; Ozalp Y; Erenmemisoglu A; van der Meer MJ; Alpan RS
Arzneimittelforschung; 2004 Sep; 54(9A):573-7. PubMed ID: 15497662
[TBL] [Abstract][Full Text] [Related]
11. Relative bio-availability of sultamicillin in healthy volunteers following administration of two tablet formulations.
Wildfeuer A; Zimmermann T; Eibel G; Lach P; Yeates R; Pfaff G
J Int Med Res; 1992; 20 Suppl 1():4A-11A. PubMed ID: 1451928
[TBL] [Abstract][Full Text] [Related]
12. In vivo bioequivalence of oral antidiabetic agents: pioglitazone tablets.
Wong H; Ozalp Y; Lainesse A; Alpan RS
Arzneimittelforschung; 2004 Sep; 54(9A):618-24. PubMed ID: 15497670
[TBL] [Abstract][Full Text] [Related]
13. Bioequivalence study of clopidogrel bisulfate film-coated tablets.
Lainesse A; Ozalp Y; Wong H; Alpan RS
Arzneimittelforschung; 2004 Sep; 54(9A):600-4. PubMed ID: 15497667
[TBL] [Abstract][Full Text] [Related]
14. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
[TBL] [Abstract][Full Text] [Related]
15. Bioequivalence study of levothyroxine tablets compared to reference tablets and an oral solution.
Koytchev R; Lauschner R
Arzneimittelforschung; 2004; 54(10):680-4. PubMed ID: 15553108
[TBL] [Abstract][Full Text] [Related]
16. Bioequivalence study of two different clopidogrel bisulfate film-coated tablets.
Richter W; Erenmemisoglu A; Van der Meer MJ; Emritte N; Tuncay E; Koytchev R
Arzneimittelforschung; 2009; 59(6):297-302. PubMed ID: 19634511
[TBL] [Abstract][Full Text] [Related]
17. Bioequivalence study of generic tablet formulations containing ethinylestradiol and chlormadinone acetate in healthy female volunteers.
Bonn M; Eydeler U; Barkworth M; Rovati LC
Arzneimittelforschung; 2009; 59(12):651-8. PubMed ID: 20108652
[TBL] [Abstract][Full Text] [Related]
18. Bioequivalence study of finasteride. Determination in human plasma by high-pressure liquid chromatography coupled to tandem mass spectrometry.
de Menezes FG; Ribeiro W; Ifa DR; de Moraes ME; de Moraes MO; De Nucci G
Arzneimittelforschung; 2001 Feb; 51(2):145-50. PubMed ID: 11258044
[TBL] [Abstract][Full Text] [Related]
19. Bioequivalence study of 2 orodispersible formulations of ondansetron 8 mg in healthy volunteers.
Cánovas M; Rios J; Domenech G; Cebrecos J; Pelagio P; Canals M; Polonio F; Cabré F
Arzneimittelforschung; 2012 Feb; 62(2):59-62. PubMed ID: 22344549
[TBL] [Abstract][Full Text] [Related]
20. Comparative bioavailability of two dexamethasone tablet formulations in Indonesian healthy volunteers.
Harahap Y; Sasongko L; Prasaja B; Indriati E; Lusthom W; Lipin
Arzneimittelforschung; 2009; 59(4):191-4. PubMed ID: 19517895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
